GR79459B - - Google Patents

Info

Publication number
GR79459B
GR79459B GR73456A GR840173456A GR79459B GR 79459 B GR79459 B GR 79459B GR 73456 A GR73456 A GR 73456A GR 840173456 A GR840173456 A GR 840173456A GR 79459 B GR79459 B GR 79459B
Authority
GR
Greece
Prior art keywords
radical
radicals
alkyl
optionally substituted
amino
Prior art date
Application number
GR73456A
Other languages
English (en)
Inventor
J G Teutsch
M Klich
J F Chantot
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of GR79459B publication Critical patent/GR79459B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
GR73456A 1983-01-10 1984-01-09 GR79459B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300273A FR2539128A1 (fr) 1983-01-10 1983-01-10 Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Publications (1)

Publication Number Publication Date
GR79459B true GR79459B (el) 1984-10-30

Family

ID=9284799

Family Applications (1)

Application Number Title Priority Date Filing Date
GR73456A GR79459B (el) 1983-01-10 1984-01-09

Country Status (11)

Country Link
EP (1) EP0114128B1 (el)
JP (2) JPS59130862A (el)
AT (1) ATE41661T1 (el)
CA (1) CA1244034A (el)
DE (1) DE3477382D1 (el)
DK (1) DK164404C (el)
ES (1) ES528742A0 (el)
FR (1) FR2539128A1 (el)
GR (1) GR79459B (el)
IE (1) IE56521B1 (el)
PT (1) PT77939B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0649696B2 (ja) * 1983-07-04 1994-06-29 富山化学工業株式会社 新規なアゼチジノン誘導体およびその塩類
AU581180B2 (en) * 1983-08-26 1989-02-16 E.R. Squibb & Sons, Inc. 1-(1h-tetrazol-5-ylalkoxy)-2-azetidinones
JPH075592B2 (ja) * 1984-06-25 1995-01-25 富山化学工業株式会社 新規なアゼチジノン誘導体およびその塩
JPH07108907B2 (ja) * 1984-06-25 1995-11-22 富山化学工業株式会社 新規なアゼチジノン誘導体またはその塩
FR2582308B1 (fr) * 1985-05-22 1987-10-09 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical tetrazolyle substitue par un radical organique clivable, leur procede de preparation et leur application comme medicaments
FR2585021B2 (fr) * 1985-07-18 1989-05-19 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidinone comportant, en position 1, un radical heterocyclique azote, leur procede de preparation et leur application comme medicaments
DE3864257D1 (de) * 1987-02-11 1991-09-19 Upjohn Co Neue n-1 substituierte beta-lactame als antibiotika.
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
WO1988006587A1 (en) * 1987-02-27 1988-09-07 The Upjohn Company ANTIBIOTIC beta-LACTAMS CONTAINING A PYRIDONE CARBOXYLIC ACID OR ACID DERIVATIVE
AU2125188A (en) * 1987-07-22 1989-02-13 Upjohn Company, The Therapeutically useful beta-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
CN103012316B (zh) * 2012-11-29 2015-03-25 浙江工业大学 N-4-甲基-1,2,3-噻二唑-4-酰基-n-取代1,3,4-噻二唑基硫脲衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468874A (en) * 1967-04-10 1969-09-23 R & L Molecular Research Ltd 6 - tetrazolylacetamido penicillanic and 7-tetrazolylacetamido cephalosporanic acids
US4186131A (en) * 1977-04-21 1980-01-29 Mead Johnson & Company Phenyltetrazolyloxy propanolamines
DE2946432A1 (de) * 1979-11-17 1981-06-11 Bayer Ag, 5090 Leverkusen Tetrazolyloxycarbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類

Also Published As

Publication number Publication date
CA1244034A (fr) 1988-11-01
IE56521B1 (en) 1991-08-28
ATE41661T1 (de) 1989-04-15
DK164404C (da) 1992-11-09
DK164404B (da) 1992-06-22
IE840036L (en) 1984-07-10
JPH0678336B2 (ja) 1994-10-05
FR2539128A1 (fr) 1984-07-13
EP0114128A1 (fr) 1984-07-25
JPH0480912B2 (el) 1992-12-21
DK7584D0 (da) 1984-01-09
FR2539128B1 (el) 1985-05-03
PT77939A (fr) 1984-02-01
DE3477382D1 (en) 1989-04-27
JPS59130862A (ja) 1984-07-27
JPH03163076A (ja) 1991-07-15
DK7584A (da) 1984-07-11
ES8407046A1 (es) 1984-08-16
PT77939B (fr) 1986-06-18
EP0114128B1 (fr) 1989-03-22
ES528742A0 (es) 1984-08-16

Similar Documents

Publication Publication Date Title
FR2539128B1 (el)
CA2143636A1 (en) Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
EP0496561A3 (en) (((2-amino-3,4-dioxo-1-cyclo-buten-1-yl)amino)alkyl)-acid derivatives
AU586248B2 (en) (Meth)-acrylic acid esters and their use
AU677852B2 (en) Acetamide derivatives and their use for modifying feeding behavior modifiers
FI102281B (fi) Menetelmä uusien erytromysiinijohdannaisten valmistamiseksi
DE69515390D1 (de) Ureido-derivate von naphtalenphosphonsäure und verfahren zu ihrer herstellung
ATE167496T1 (de) Polyurethanharze, verfahren zu ihrer herstellung sowie ihre verwendung in wasserverdünnbaren überzugsmitteln
ATE132849T1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
ZA894777B (en) New substituted sulphonamides
ATE167187T1 (de) Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE3881407D1 (de) Cinnolin-karbonsaeure-amide und verfahren zu deren herstellung.
ATE112283T1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
FI103046B1 (fi) Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemijohdannaisten valmistamiseksi
DE69316380D1 (de) Benzenealkancarbonsäuren für kardiovaskulare krankheiten
ATE182330T1 (de) 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische zusammensetzung
HUT50354A (en) Process for producing new s-adenosylmethionine decarboxilase inhibitors
HUT50464A (en) Process for producing phenothiazin derivatives
DE69708624D1 (de) Promotor eines polymerisationskatalysator
ATE195145T1 (de) Synthese von homochiralen 2-hydroxysäuren
DE3768469D1 (de) N-substituierte, estergruppen enthaltende acrylamide.
FR2338041A1 (fr) Nouveaux acides furobenzoxazolyl-acethydroxamiques, leur procede de preparation et leur application en therapeutique
ATE47839T1 (de) N-(2,6-disubstituierte aryl)-n'pyridinylharnstoffe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DE59300004D1 (de) 2,3-Dihydroxychinoxalinverbindungen.